STK11, also known as LKB1 (Liver kinase B1), whose loss-function mutation occurs in approximately 10% of NSCLC, is a tumor suppressor gene that plays a critical role in cellular processes such as metabolic reprogramming, cell polarity, and proliferation (14–17). This evidence concerns the gene STK11 and non-small cell lung carcinoma.